{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:14:38Z","timestamp":1791825278455,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ihj.2018.01.034","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T14:07:05Z","timestamp":1517494025000},"page":"S8-S12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S3","title":["To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia"],"prefix":"10.1016","volume":"70","author":[{"given":"Deepak","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.S.","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuwanesh","family":"Kandpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Passey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Makhija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kr.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2018.01.034_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9149(92)90744-J","article-title":"Prevalence of coronary artery disease in Asian Indians","volume":"70","author":"Enas","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.95.1.1","article-title":"Small LDL, atherogenic dyslipidemia and the metabolic syndrome","volume":"95","author":"Grundy","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.01.034_bib0015","doi-asserted-by":"crossref","first-page":"17F","DOI":"10.1016\/S0002-9149(99)00213-1","article-title":"Diabetes, hyperlipidemia and coronary artery disease","volume":"83","author":"Haffnar","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0020","doi-asserted-by":"crossref","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study","volume":"9","author":"Joshi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ihj.2018.01.034_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amjcard.2005.07.108","article-title":"Comparative safety of atorvastatin 80\u2009mg vs 10\u2009mg derived from analysis of 49 completed trials in 14236 patients","volume":"97","author":"Newman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0030","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ihj.2018.01.034_bib0035","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1248\/bpb.26.1681","article-title":"Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin","volume":"26","author":"Kanda","year":"2003","journal-title":"Biol Pharm Bull"},{"issue":"December (6)","key":"10.1016\/j.ihj.2018.01.034_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2013the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovas Drugs Ther"},{"key":"10.1016\/j.ihj.2018.01.034_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MOL.0b013e32834b4994","article-title":"Statins and the risk of new-onset diabetes: a review of recent evidence","volume":"22","author":"Preiss","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"Waters","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/M14-0126","article-title":"2013 ACC\/AHA Cholesterol Guideline Panel: treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology\/American Heart Association cholesterol guideline","volume":"160","author":"Stone","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ihj.2018.01.034_bib0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.amjcard.2007.01.028","article-title":"Comparison of rosuvastatin versus atorvastatin in south Asian patients at risk of coronary heart disease (from the IRIS Trial)","volume":"99","author":"Deedwania","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0065","first-page":"97","article-title":"Post marketing study of clinical experience of atorvastatin 80mg vs 40mg in indian patients with acute coronary syndrome- a randomized, multicenter study (CURE-ACS)","volume":"61","author":"Kaul","year":"2013","journal-title":"J Assoc Phys India"},{"issue":"June (6)","key":"10.1016\/j.ihj.2018.01.034_bib0070","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1194\/jlr.P002816","article-title":"Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database","volume":"51","author":"Philip Barter","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ihj.2018.01.034_bib0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.01.034_bib0080","doi-asserted-by":"crossref","first-page":"f2610","DOI":"10.1136\/bmj.f2610","article-title":"Risk of incident diabetes among patients treated with statins: population based study","volume":"346","author":"Aleesa","year":"2013","journal-title":"BMJ"},{"issue":"January (1)","key":"10.1016\/j.ihj.2018.01.034_bib0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2004.07.025","article-title":"Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia -NASDAC Study","volume":"149","author":"Jones","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2018.01.034_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function and performance","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217305321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217305321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T06:27:54Z","timestamp":1547274474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483217305321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":18,"alternative-id":["S0019483217305321"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2018.01.034","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To study the effect of high dose Atorvastatin 40mg versus 80mg in patients with dyslipidemia","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2018.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}